XML 132 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Common Stock and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share Based Termination Liability [Abstract]  
Schedule of Common Stock Reserved for Issuance

Common stock reserved for issuance as of December 31, 2024 and 2023, is as follows:

 

   2024   2023 
Series A convertible preferred stock   
    1,573,999 
Series B convertible preferred stock   
    2,511,007 
Series C convertible preferred stock   
    1,498,516 
Series D convertible preferred stock   
    1,312,722 
Series E convertible preferred stock   
    1,152,329 
Warrants outstanding for future issuance of convertible preferred stock   
    86,877 
Warrants outstanding for future issuance of Common stock   14,583,333    1,337,169 
Stock options and restricted stock units   7,078,178    1,657,017 
Stock options and restricted stock units available for future issuance   698,682    670,477 
Total shares of common stock reserved   22,360,193    11,800,113 
Schedule of Option Award Activity for Service-Based Stock Options Granted

Option award activity for service-based stock options granted as of December 31, 2024, was as follows:

 

   Number of
options
outstanding
   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Life (Years)
   Aggregate
Intrinsic Value
(in thousand)
 
Balances as of January 1, 2023   970,134   $17.77    6.1   $2,561 
Granted   
    
        
 
Exercised   
    
        
 
Expired   (380,917)   15.95        
 
Forfeited   (153,360)   22.87        
 
Balances as of December 31, 2023   435,857   $17.60    4.8   $754 
Granted   5,650,566    0.34        
 
Exercised   
    
        
 
Expired   (1,179)   4.37        
 
Forfeited   
    
        
 
Balances as of December 31, 2024   6,085,244   $1.58    9.5   $802 
Options vested and exercisable at December 31, 2024   3,107,320   $2.71    9.1   $380 

A summary of the Company’s performance milestone-based stock options activity and related information is as follows:

 

   Number of
options
outstanding
   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Life (Years)
   Aggregate
Intrinsic Value
(in thousands)
 
Balances as of January 1, 2023   105,090   $20.85    5.6   $463 
Granted   
    
        
 
Exercised   
    
        
 
Expired   
    
        
 
Forfeited   (2,949)   
        
 
Balances as of December 31, 2023   102,141   $20.85    6.6   $
 
Granted   
    
        
 
Exercised   
    
        
 
Expired   
    
        
 
Forfeited   
    
        
 
Balances as of December 31, 2024   102,141   $20.85    5.6   $
 
Vested and exercisable at December 31, 2024   34,047   $20.85    5.6   $
 
Schedule of RSU Activity and Related Information

A summary of the Company’s RSU activity and related information is as follows:

 

   Number of
RSUs
Outstanding
   Weighted-
Average
Grant Date
Fair Value
Per Share
 
Balances as of January 1, 2023   620,756   $22.11 
Granted   1,011,680    9.95 
Vested   
    
 
Forfeited   (514,601)   16.39 
Balances as of December 31, 2023   1,117,835   $13.64 
Granted   990,975    9.54 
Vested   (1,062,212)   13.64 
Forfeited   (155,805)   9.13 
Balances as of December 31, 2024   890,793   $9.69 
Schedule of Stock-based Compensation Expense

The following table summarizes stock-based compensation expense recorded in each component of operating expenses in the Company’s consolidated statements of operations and comprehensive loss (in thousands):

 

   Year Ended December 31, 
   2024   2023 
Research and development  $3,000   $4 
Sales and marketing   1,446    1 
General and administrative   13,718    638 
Total stock-based compensation expense  $18,164   $643 
Schedule of Fair Value of Employee Service-Based Option Grants

The following assumptions were used to calculate the fair value of employee service-based option grants made during the year ended December 31, 2024:

 

    2024 
Expected dividend yield(1)   
 
Risk-free interest rate(2)   4.17% - 4.20
Expected volatility(3)   85.00%- 86.20%
Expected life (in years)(4)   0.76 - 6.50 
Fair value of common stock  $0.34 - $9.00 
(1)The Company has no history or expectation of paying cash dividends on its common stock and, thus, has assumed a zero-dividend rate.

(2)The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant.

(3)To determine the expected volatility used above, the Company used the average volatility of a peer group of representative public companies.

(4)The expected life or term of the options represents the period of time that options granted are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term).